Metraipolis › archive › dc_684ec0919e89
Redefining endpoints in heart failure clinical trials: the emerging role of wearable technologies in contemporary trial design — Europe PMC PMID:41286276
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41286276
- DOI
- 10.1007/s10741-[numero omesso]-0
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T06:42:27.510Z
- SHA-256 of the archived text
636c9f8a33780b812e074b383f8b96bcd992f13ec1ea20bd66d7fdb634ef4dd2- Stable URL of this page
https://metraipolis.com/documento/dc_684ec0919e89
How to cite
Redefining endpoints in heart failure clinical trials: the emerging role of wearable technologies in contemporary trial design — Europe PMC PMID:41286276 — Europe PMC (en), https://europepmc.org/article/MED/41286276 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_684ec0919e89 (Metraipolis archive dc_684ec0919e89, sha256 636c9f8a33780b812e074b383f8b96bcd992f13ec1ea20bd66d7fdb634ef4dd2)
BibTeX
@misc{dc684ec0919e89,
title = {Redefining endpoints in heart failure clinical trials: the emerging role of wearable technologies in contemporary trial design — Europe PMC PMID:41286276},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41286276},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_684ec0919e89; sha256 636c9f8a33780b812e074b383f8b96bcd992f13ec1ea20bd66d7fdb634ef4dd2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41286276. Agents can read the archived copy with the MCP tool read_document.